ArticleThe European respiratory journal2026
Genome-wide association study of idiopathic pulmonary fibrosis susceptibility using clinically curated European ancestry datasets.
Abstract readLetter
In one paragraph
Article in The European respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Circulating lipids, lipoproteins, and the risk of idiopathic pulmonary fibrosis: a cohort study and genetic analysis.Journal of lipid research · 2026Article
- Genes, gut microbiome and lungs: untangling the web of idiopathic pulmonary fibrosis.ERJ open research · 2026Article
- Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variants.medRxiv : the preprint server for health sciences · 2026Article
- TGF-β Signaling as a Pathological Continuum Linking Idiopathic Pulmonary Fibrosis and Lung Cancer.Cells · 2026Review
- A Multispecies, Modality-Agnostic Scalable In Vivo Mosaic Screening Platform for Therapeutic Target Discovery.bioRxiv : the preprint server for biology · 2026Article
- Contribution of dominant and recessive model effects to the genetic architecture of Idiopathic Pulmonary Fibrosis.medRxiv : the preprint server for health sciences · 2026Article
- Proteome-Wide Serological Profiling Reveals Broad Elevation of EBV Immunity in Idiopathic Pulmonary Fibrosis.International journal of molecular sciences · 2026Article
- Rubiadin-1-methyl ether alleviates bleomycin induced pulmonary fibrosis.Scientific reports · 2026Article
- Multi-omics approaches in idiopathic pulmonary fibrosis: from molecular mechanisms to therapeutic targets and precision medicine.Frontiers in pharmacology · 2026Review
- Exploring the Cellular and Molecular Landscape of Idiopathic Pulmonary Fibrosis: Integrative Multi-Omics and Single-Cell Analysis.Biomedicines · 2025Article
- An Overview of the Role of Genetic factors in Idiopathic Pulmonary Fibrosis: Insights from Epidemiology to Prognosis.International journal of medical sciences · 2025Review
Corrections and comments
- Update of
Authors and funding
48 authors.
Daniel ChinDivision of Public Health and Epidemiology, School of Medical Sciences, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0002-7349-895X
Tamara Hernandez-BeeftinkDivision of Public Health and Epidemiology, School of Medical Sciences, University of Leicester, Leicester, UK.
Lauren DonoghueGenentech, South San Francisco, CA, USA.
Beatriz Guillen-GuioDivision of Public Health and Epidemiology, School of Medical Sciences, University of Leicester, Leicester, UK.ORCID https://orcid.org/0000-0002-3703-1738
Olivia C LeavyDivision of Public Health and Epidemiology, School of Medical Sciences, University of Leicester, Leicester, UK.
Ayodeji AdegunsoyeUniversity of Chicago, Chicago, IL, USA.
Helen L BoothUniversity College London Hospitals, London, UK.
CleanUP-IPF Investigators of the Pulmonary Trials Cooperative
William A FahyGlaxoSmithKline, London, UK.
Tasha E FingerlinNational Jewish Health, Denver, CO, USA.
Bibek GooptuUniversity Hospitals of Leicester NHS Trust, Leicester, UK.
Ian P HallCentre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK.
Simon P HartUniversity of Hull, Hull, UK.ORCID https://orcid.org/0000-0003-4606-9559
Mike R HillUniversity of Oxford, Oxford, UK.
Nik HiraniUniversity of Edinburgh, Edinburgh, UK.
Simon R JohnsonCentre for Respiratory Research, NIHR Biomedical Research Centre and Biodiscovery Institute, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK.ORCID https://orcid.org/0000-0002-9837-2763
Naftali KaminskiYale School of Medicine, New Haven, CT, USA.ORCID https://orcid.org/0000-0001-5917-4601
Jose Miguel Lorenzo-SalazarGenomics Division, Instituto Tecnologico y de Energias Renovables, Santa Cruz de Tenerife, Spain.ORCID https://orcid.org/0000-0002-5135-2861
Shwu-Fan MaUniversity of Virginia, Charlottesville, VA, USA.ORCID https://orcid.org/0000-0002-3058-9480
Robin J McAnultyUniversity College London, London, UK.
Mark I McCarthyGenentech, South San Francisco, CA, USA.
Amy D StockwellGenentech, South San Francisco, CA, USA.
Toby M MaherNIHR Imperial Biomedical Research Unit, National Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-7192-9149
Ann B MillarUniversity of Bristol, Bristol, UK.
Philip L MolyneauxNational Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-1301-8800
Maria Molina-MolinaCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Vidya NavaratnamDepartment of Respiratory Medicine, Sir Charles Gardiner Hospital, Perth, Australia.ORCID https://orcid.org/0000-0002-2914-8012
Margaret NeighborsGenentech, South San Francisco, CA, USA.
Justin M OldhamUniversity of Michigan, Ann Arbor, MI, USA.
Helen ParfreyRoyal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Gauri SainiUniversity of Nottingham, Nottingham, UK.
Ian SayersCentre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK.ORCID https://orcid.org/0000-0001-5601-5410
X Rebecca ShengGenentech, South San Francisco, CA, USA.
Iain D StewartImperial College London, London, UK.ORCID https://orcid.org/0000-0002-1340-2688
Mary E StrekUniversity of Chicago, Chicago, IL, USA.
Martin D TobinDivision of Public Health and Epidemiology, School of Medical Sciences, University of Leicester, Leicester, UK.
Moira K B WhyteUniversity of Edinburgh, Edinburgh, UK.
Maria C ZarconeNIHR Imperial Biomedical Research Unit, National Heart and Lung Institute, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-1884-0062
Yingze ZhangUniversity of Pittsburgh, Pittsburgh, PA, USA.
Fernando MartinezUMass Chan Medical School, Worcester, MA, USA.
Brian L YaspanGenentech, South San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-3787-2510
Carl J ReynoldsImperial College, London, UK.
David A SchwartzUniversity of Colorado Medicine, Aurora, CO, USA.
Carlos FloresCentro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Imre NothUniversity of Virginia, Charlottesville, VA, USA.
R Gisli JenkinsNIHR Imperial Biomedical Research Unit, National Heart and Lung Institute, Imperial College London, London, UK.
Richard J AllenDivision of Public Health and Epidemiology, School of Medical Sciences, University of Leicester, Leicester, UK.
Louise V WainDivision of Public Health and Epidemiology, School of Medical Sciences, University of Leicester, Leicester, UK lvw1@leicester.ac.uk.ORCID https://orcid.org/0000-0003-4951-1867
Funding
Elucidating the Genomic Determinants of Outcomes in Idiopathic Pulmonary FibrosisK23HL138190 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI OLDHAM, JUSTIN M · 2017 to 2021
$914kDerivation and validation of a clinical-molecular signature to predict fibrotic progression and treatment response in patients with autoimmune interstitial lung diseaseR56HL158935 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI OLDHAM, JUSTIN M · 2021 to 2021
$400kNHLBI NIH HHS K23 HL138190NHLBI NIH HHS R56 HL158935Wellcome Trust
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.